Literature DB >> 20212134

Leveraging leptin for type I diabetes?

Daniel Kraus1, Mark A Herman, Barbara B Kahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20212134      PMCID： PMC2841872          DOI： 10.1073/pnas.1000736107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Whatever happened to leptin?

Authors:  M Chicurel
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

Authors:  M A Jacobs; E T Keulen; K Kanc; S Casteleijn; P Scheffer; W Devillé; R J Heine
Journal:  Diabetes Care       Date:  1997-08       Impact factor: 19.112

3.  Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity.

Authors:  May-Yun Wang; Lelio Orci; Mariella Ravazzola; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

4.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Authors:  S B Heymsfield; A S Greenberg; K Fujioka; R M Dixon; R Kushner; T Hunt; J A Lubina; J Patane; B Self; P Hunt; M McCamish
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

5.  Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.

Authors:  N Chinookoswong; J L Wang; Z Q Shi
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

Review 6.  Monogenic obesity in humans.

Authors:  I Sadaf Farooqi; Stephen O'Rahilly
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

Review 7.  Leptin.

Authors:  R S Ahima; J S Flier
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

8.  Leptin therapy in insulin-deficient type I diabetes.

Authors:  May-yun Wang; Lijun Chen; Gregory O Clark; Young Lee; Robert D Stevens; Olga R Ilkayeva; Brett R Wenner; James R Bain; Maureen J Charron; Christopher B Newgard; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

9.  Leptin as an adjunct of insulin therapy in insulin-deficient diabetes.

Authors:  F Miyanaga; Y Ogawa; K Ebihara; S Hidaka; T Tanaka; S Hayashi; H Masuzaki; K Nakao
Journal:  Diabetologia       Date:  2003-08-20       Impact factor: 10.122

10.  Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns.

Authors:  Alina Gavrila; C-K Peng; Jean L Chan; Joseph E Mietus; Ary L Goldberger; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958
View more
  8 in total

1.  Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches.

Authors:  Maureen A O'Malley; Karola Stotz
Journal:  Philos Ethics Humanit Med       Date:  2011-01-28       Impact factor: 2.464

2.  Leptin downregulates expression of the gene encoding glucagon in alphaTC1-9 cells and mouse islets.

Authors:  L Marroquí; E Vieira; A Gonzalez; A Nadal; I Quesada
Journal:  Diabetologia       Date:  2011-01-14       Impact factor: 10.122

Review 3.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

4.  Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering.

Authors:  Mikio Takanashi; Yoshino Taira; Sachiko Okazaki; Satoru Takase; Takeshi Kimura; Cheng Cheng Li; Peng Fei Xu; Akari Noda; Ichiro Sakata; Hidetoshi Kumagai; Yuichi Ikeda; Yoko Iizuka; Naoya Yahagi; Hitoshi Shimano; Jun-Ichi Osuga; Shun Ishibashi; Takashi Kadowaki; Hiroaki Okazaki
Journal:  J Atheroscler Thromb       Date:  2017-04-12       Impact factor: 4.928

5.  Therapeutic value of brown adipose tissue: Correcting metabolic disease through generating healthy fat.

Authors:  Subhadra C Gunawardana
Journal:  Adipocyte       Date:  2012-10-01       Impact factor: 4.534

6.  The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis.

Authors:  Andrea Granados; Elizabeth A Beach; Andrew J Christiansen; Bruce W Patterson; Michael Wallendorf; Ana María Arbeláez
Journal:  J Cyst Fibros       Date:  2021-06-26       Impact factor: 5.527

7.  'Fat's chances': Loci for phenotypic dispersion in plasma leptin in mouse models of diabetes mellitus.

Authors:  Guy M L Perry
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

8.  Biochemical, serological, and genetic aspects related to gene HLA-DQB1 and its association with type 1 diabetes mellitus (T1DM).

Authors:  Gur Charn Singh; Mehboob Ahmed; Muhammad Zaid; Shahida Hasnain
Journal:  Mol Genet Genomic Med       Date:  2020-03-06       Impact factor: 2.183
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.